Skip to main content
CRISIL Ltd. logo

CRISIL Ltd. — Investor Relations & Filings

Ticker · CRISIL ISIN · INE007A01025 LEI · 335800XLQ1LWF1M6KM87 BSE.NS Financial and insurance activities
Open in API
Filings indexed 1,780 across all filing types
Latest filing 2025-01-03 Regulatory Filings
Country IN India
Listing BSE.NS CRISIL

About CRISIL Ltd.

https://www.crisil.com/

CRISIL Ltd. is a global analytical company providing ratings, research, and risk and policy advisory services. As a subsidiary of S&P Global, it delivers independent data, insights, and solutions to financial institutions, corporations, and governments. The company's core business includes credit ratings for diverse debt instruments, comprehensive equity and economic research, and specialized risk management frameworks. CRISIL serves a broad spectrum of clients, from small and medium enterprises to large multinational corporations and institutional investors. Its service portfolio encompasses credit risk assessment, investment research, data analytics, and advisory services focused on infrastructure and policy. By leveraging advanced technology and deep domain expertise, the company provides critical decision-making tools that enhance market transparency and efficiency. Its global delivery model supports international financial markets with high-quality analytical outputs.

Recent filings

Filing Released Lang Actions
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 100% confidence The document is a certificate issued under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, certifying that details of securities dematerialized/rematerialized during the quarter ended December 31, 2024, have been furnished to stock exchanges. It is a compliance certificate from the Registrar and Transfer Agents to the stock exchanges and the company secretary. The document is short (3499 characters) and primarily serves as a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or other report content. It is not an announcement of a report publication but a regulatory filing to comply with SEBI regulations. Therefore, it fits best under Regulatory Filings (RNS).
2025-01-03 English
Please find attached the certificate issued under Regulation 74(5) of SEBI (DP) Regulations, 2018.
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, certifying that details of securities dematerialized/rematerialized during the quarter ended December 31, 2024, have been furnished to stock exchanges. It is a compliance certificate from the Registrar and Transfer Agents to the stock exchanges and the company secretary. The document is short (3499 characters) and primarily serves as a regulatory attestation rather than a financial report or announcement of financial results. It does not contain financial statements or detailed financial data. Therefore, it fits the category of Regulatory Filings (RNS), which includes officer certifications and compliance documents that do not fit other specific categories.
2025-01-03 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing them about an upcoming Board of Directors meeting scheduled for February 10, 2025. The meeting will consider and approve audited consolidated and standalone financial results for the quarter and year ended December 31, 2024, and recommend a final dividend. The document also mentions the commencement of a 'No Trading Window' as per the Insider Trading Code. The document is short (1456 characters) and serves as a notification of a future event rather than containing any financial results or detailed report. Therefore, it is an announcement related to board meeting scheduling and not the actual financial report or dividend declaration. This fits best under Regulatory Filings (RNS) as a general regulatory announcement and notification to exchanges.
2025-01-02 English
Board Meeting — Financial Results/Dividend
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing them about an upcoming Board of Directors meeting scheduled for February 10, 2025. The meeting will consider and approve audited consolidated and standalone financial results for the quarter and year ended December 31, 2024, and recommend a final dividend. The document also mentions the commencement of a 'No Trading Window' period as per the Insider Trading Code. The document is short (1456 characters) and serves as a notification of a future event rather than containing any financial results or detailed report. It does not contain actual financial data or detailed analysis. Therefore, it is an announcement related to board meeting scheduling and not the financial report itself. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-01-02 English
Please find attached intimation for closure of trading window of the Company.
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing about an upcoming Board of Directors meeting scheduled for February 10, 2025. The meeting will consider and approve audited consolidated and standalone financial results for the quarter and year ended December 31, 2024, and recommend a final dividend. The document also mentions the commencement of a 'No Trading Window' as per the Insider Trading Code. The document is short (1456 characters) and serves as a notification of a future event rather than containing any financial results or detailed reports. It does not contain actual financial data or detailed analysis. Therefore, it is an announcement related to board meeting scheduling and not the financial report itself. This fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2025-01-02 English
CRISIL LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2025 ,inter alia, to consider and approve the audited consolidated and standalone ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing them about an upcoming Board of Directors meeting scheduled for February 10, 2025. The meeting will consider and approve audited consolidated and standalone financial results for the quarter and year ended December 31, 2024, and recommend a final dividend. The document also mentions the commencement of a 'No Trading Window' period for employees. The document is short (1456 characters) and serves as a notification of a future event rather than containing any financial results or detailed report. It does not contain actual financial data or results, nor is it a certification or legal proceeding. Therefore, it is best classified as a Regulatory Filing (RNS), which is the fallback category for such announcements that do not fit other specific categories.
2025-01-02 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.